Monday, January 2, 2017

Six Stocks to keep closely this Week $NVLS $TRIL $DVAX $DRNA $IOTS $HSGX

Nivalis Therapeutics, Inc.
NVLS ---> This stock is getting attention from the Buyers! It is on the verge of a Big Breakout and, if do that on volume, it could make a great move into its 20EMA, which is my initial target!! Extremely oversold, NVLS is showing positive divergences on MACD and CMF indicators and is showing too, an increase of the Accumulation!! Worth watching closely!


Trillium Therapeutics Inc.
TRIL --->  Last week i opened a strong position on this stock because i believe that price reach the Bottom and, at these levels, is a very cheap price!! MACD is showing an intense bullish activity, which a major move could happen any moment!! 20EMA is my initial target!!


Dynavax Technologies Corp.
 DVAX ---> Is forming and interesting base here!! With MACD showing a strong positive BIAS, i expect a upside movement any moment toward its 20EMA, which is my initial target!

Dicerna Pharmaceuticals, Inc.
DRNA ---> This stock found his Bottom between $2.69 and $2.81! As we can see, it hit on Friday the low of $2.76,  initiating immediately a recovery process!! At these levels, this stock is a Buy with both Hands.



Adesto Technologies Corp.
IOTS ---> Has been forming a solid base on the top of its 20EMA!! I expect that it take off any moment and possible break of its 50EMA with decent volume, should make it test the $2.10 level easily!! Keep this setup under your eye! It should move fast


Histogenics Corp.
HSGX ---> Another one that hit the bottom and starting immediately the recovery process! Also, it is a Buy stock with both hands with initial target its 20EMA!! Accumulation is rising strongly! On radar

Disclaimer

Here's a friendly reminder: all charts shared here are powerful tools based on major technical indicators. However, it's crucial to remember that stock suitability depends on your individual strategy. 🛠️ I must emphasize that good stock performance isn't solely determined by technical data. 💡 As always, trade cautiously, and I cannot be held responsible for any trade outcomes. Remember, I'm not a financial advisor.